Skip to main content
Equibles
SOPH logo

SOPH · SOPHiA GENETICS SA

Track SOPH — free

Use SOPH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about SOPH

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.50 -0.12 (-1.57%) At close · Aug 14
Market Cap
$638.46M
Shares
85.13M

SOPHiA GENETICS SA Earnings Call Transcripts

Every quarterly earnings call for SOPHiA GENETICS SA (SOPH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY26 · Q2
2026-08-04
SOPHiA GENETICS Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-04
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
SOPHiA GENETICS SA Q1 FY2026 Earnings Call
Confident tone SOPHiA DDM Platform and AI MSK Access and Biopharma Path to Profitability and Efficiency
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-12-31
SOPHiA GENETICS SA Q4 FY2025 Earnings Call
Confident tone Customer wins and U.S. growth Guidance and 2026 outlook Platform modernization and scalability
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
SOPHiA GENETICS SA Q3 FY2025 Earnings Call
Confident tone MSK-ACCESS liquid biopsy franchise Companion diagnostic (CDx) partnerships New customer signings and expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-05
SOPHiA GENETICS SA Q2 FY2025 Earnings Call
Confident tone MSK-ACCESS liquid biopsy application Revenue growth and BioPharma headwinds AstraZeneca partnership
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
SOPHiA GENETICS SA Q1 FY2025 Earnings Call
Confident tone MSK-ACCESS and MSK-IMPACT applications Biopharma partnerships Platform scalability and AI
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
SOPHiA GENETICS SA Q4 FY2024 Earnings Call
Confident tone 2025 Growth Drivers New Application Launches (MSK) 2025 Financial Guidance
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
SOPHiA GENETICS SA Q3 FY2024 Earnings Call
Positive tone Leadership changes Cost discipline and cash burn MSK-ACCESS powered with SOPHiA DDM
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
SOPHiA GENETICS SA Q2 FY2024 Earnings Call
Positive tone BioPharma headwinds and restructuring Platform and product launches New customer signings and bookings
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
SOPHiA GENETICS SA Q1 FY2024 Earnings Call
Positive tone Backlog, bookings, and new logos Biopharma business and deal delays Applications: solid tumor, HRD, liquid biopsy, MSK Access
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
SOPHiA GENETICS SA Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
SOPHiA GENETICS SA Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
SOPHiA GENETICS SA Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
SOPHiA GENETICS SA Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
SOPHiA GENETICS SA Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
SOPHiA GENETICS SA Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
SOPHiA GENETICS SA Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
SOPHiA GENETICS SA Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
SOPHiA GENETICS SA Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
SOPHiA GENETICS SA Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts CIK 1840706 CUSIP H82027105 13F (30d) 69 filings 69 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)